Elisa Giovannetti

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2018-12 TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression in NATURE COMMUNICATIONS
  • 2018-11-08 Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study in BRITISH JOURNAL OF CANCER
  • 2018-07 Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-01 A synthetic lethal bullet in NATURE NANOTECHNOLOGY
  • 2017-12 Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing in SCIENTIFIC REPORTS
  • 2017-12 Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2017-12 Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation in SCIENTIFIC REPORTS
  • 2017-11 Erratum to: miRNAs: micro-managers of anticancer combination therapies in ANGIOGENESIS
  • 2017-05 miRNAs: micro-managers of anticancer combination therapies in ANGIOGENESIS
  • 2017 Liquid Biopsy in Esophageal, Gastric, and Pancreatic Cancers in LIQUID BIOPSY IN CANCER PATIENTS
  • 2017 Immunotherapy in NSCLC: A Promising and Revolutionary Weapon in IMMUNOTHERAPY
  • 2016-07 Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016 The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis in CANCER DRUG RESISTANCE
  • 2015-12 MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized therapy in CLINICAL EPIGENETICS
  • 2015-08 MiRNAs and Their Interference with the Main Molecular Mechanisms Responsible for Drug Resistance in Pancreatic Cancer in CURRENT PHARMACOLOGY REPORTS
  • 2015-07 Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2015-05 Usefulness of Measuring microRNAs in Bile and Plasma for Pancreatic Ductal Adenocarcinoma Diagnosis in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2015 Pharmacology and Clinical Development of New Molecularly Targeted Agents in TARGETED THERAPIES FOR SOLID TUMORS
  • 2014-01 Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia in BRITISH JOURNAL OF CANCER
  • 2013-12 USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy in MOLECULAR CANCER
  • 2013-07 MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1 in APOPTOSIS
  • 2011-11 Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin in BRITISH JOURNAL OF CANCER
  • 2011-03-24 Analysis of Drug Interactions in CANCER CELL CULTURE
  • 2010-12 Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients in BMC CANCER
  • 2010-08 Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010-06 Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer in THE PHARMACOGENOMICS JOURNAL
  • 2009-04 Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib in BRITISH JOURNAL OF CANCER
  • 2008-09 Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells in BRITISH JOURNAL OF CANCER
  • 2008-07 Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma in LABORATORY INVESTIGATION
  • 2007-03 Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels in BRITISH JOURNAL OF CANCER
  • 2006-08 In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients in BRITISH JOURNAL OF CANCER
  • 2005-07 Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma in BRITISH JOURNAL OF CANCER
  • 2005-02 Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.16872.3a", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.12380.38", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.10041.34", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5395.a", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5284.b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.10776.37", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.144189.1", 
            "type": "Organization"
        "familyName": "Giovannetti", 
        "givenName": "Elisa", 
        "id": "sg:person.0577505063.56", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_498.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0577505063.56'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0577505063.56'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0577505063.56'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0577505063.56'


    This table displays all metadata directly associated to this object as RDF triples.

    37 TRIPLES      11 PREDICATES      21 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0577505063.56 schema:affiliation N28217f79c0f740e89d1d142960eec88b
    2 https://www.grid.ac/institutes/grid.10041.34
    3 https://www.grid.ac/institutes/grid.10776.37
    4 https://www.grid.ac/institutes/grid.12380.38
    5 https://www.grid.ac/institutes/grid.144189.1
    6 https://www.grid.ac/institutes/grid.38142.3c
    7 https://www.grid.ac/institutes/grid.48336.3a
    8 https://www.grid.ac/institutes/grid.5284.b
    9 https://www.grid.ac/institutes/grid.5395.a
    10 schema:familyName Giovannetti
    11 schema:givenName Elisa
    12 schema:identifier Nb8ebdc5a70d1487ca9be28cc9c54f032
    13 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56
    14 https://orcid.org/0000-0002-7565-7504
    15 schema:sdDatePublished 2019-03-07T14:45
    16 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    17 schema:sdPublisher Ne30bb693c6a243e382b45ce1b4d97671
    18 sgo:license sg:explorer/license/
    19 sgo:sdDataset persons
    20 rdf:type schema:Person
    21 N28217f79c0f740e89d1d142960eec88b schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
    22 sgo:isCurrent true
    23 rdf:type schema:OrganizationRole
    24 Nb8ebdc5a70d1487ca9be28cc9c54f032 schema:name orcid_id
    25 schema:value 0000-0002-7565-7504
    26 rdf:type schema:PropertyValue
    27 Ne30bb693c6a243e382b45ce1b4d97671 schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 https://www.grid.ac/institutes/grid.10041.34 schema:Organization
    30 https://www.grid.ac/institutes/grid.10776.37 schema:Organization
    31 https://www.grid.ac/institutes/grid.12380.38 schema:Organization
    32 https://www.grid.ac/institutes/grid.144189.1 schema:Organization
    33 https://www.grid.ac/institutes/grid.16872.3a schema:Organization
    34 https://www.grid.ac/institutes/grid.38142.3c schema:Organization
    35 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    36 https://www.grid.ac/institutes/grid.5284.b schema:Organization
    37 https://www.grid.ac/institutes/grid.5395.a schema:Organization

    Preview window. Press ESC to close (or click here)